Concurrent chemoradiotherapy with protracted infusion of 5-fluorouracil (5 FU) and cisplatin for locally advanced resectable esophageal cancer: A retrospective study

被引：0
|
作者：
Almhanna, Khaldoun [1 ]
Hoffe, Sarah [1 ]
Shridhar, Ravi [1 ]
Strosberg, Jonathan R. [1 ]
Dinwoodie, William R. [1 ]
Meredith, Kenneth [1 ]
机构：
[1] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 04期
关键词：
D O I：
10.1200/jco.2013.31.4_suppl.119
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
119
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Concurrent chemoradiotherapy in esophageal cancer; Comparison between intermittent high dose cisplatin with 5-fluorouracil and daily low dose cisplatin with continuous low dose infusion of 5-fluorouracil
    Sal, H
    Mitsumori, M
    Araki, N
    Okumura, S
    Nishimura, Y
    Hiraoka, M
    RADIOLOGY, 2002, 225 : 415 - 415
  • [22] Concurrent chemoradiotherapy for esophageal cancer: Comparison between intermittent standard-dose cisplatin with 5-fluorouracil and daily low-dose cisplatin with continuous infusion of 5-fluorouracil
    Sai H.
    Mitsumori M.
    Yamauchi C.
    Araki N.
    Okumura S.
    Nagata Y.
    Nishimura Y.
    Hiraoka M.
    International Journal of Clinical Oncology, 2004, 9 (3) : 149 - 153
  • [23] Chemoradiotherapy using low-dose protracted infusion of 5-FU alone is as effective as 5-FU combined with cisplatin for Advanced esophageal cancer
    Sasamoto, R.
    Tsuchida, E.
    Abe, E.
    Fukuda, T.
    Kawaguchi, G.
    Sasai, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S290 - S290
  • [24] Feasibility of chemoradiation therapy with protracted infusion of 5-fluorouracil for esophageal cancer patients not suitable for cisplatin
    Burmeister B.H.
    Walpole E.T.
    Burmeister E.A.
    Thomas J.
    Thomson D.B.
    Harvey J.A.
    Smithers B.M.
    Gotley D.C.
    International Journal of Clinical Oncology, 2005, 10 (4) : 256 - 261
  • [25] Neoadjuvant chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil for esophageal cancer
    Emi, Manabu
    Hihara, Jun
    Hamai, Yoichi
    Aoki, Yoshiro
    Okada, Morihito
    Kenjo, Masahiro
    Murakami, Yuji
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (06) : 1499 - 1505
  • [26] Neoadjuvant chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil for esophageal cancer
    Manabu Emi
    Jun Hihara
    Yoichi Hamai
    Yoshiro Aoki
    Morihito Okada
    Masahiro Kenjo
    Yuji Murakami
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 1499 - 1505
  • [27] Efficacy of concurrent chemoradiotherapy with 5-fluorouracil or gemcitabine in locally advanced biliary tract cancer
    Yi, Seung Woo
    Kang, Dae Ryong
    Kim, Kyung Sik
    Park, Mi Suk
    Seong, Jinsil
    Park, Jeong Youp
    Bang, Seung Min
    Song, Si Young
    Chung, Jae Bock
    Park, Seung Woo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (01) : 191 - 198
  • [28] Efficacy of concurrent chemoradiotherapy with 5-fluorouracil or gemcitabine in locally advanced biliary tract cancer
    Seung Woo Yi
    Dae Ryong Kang
    Kyung Sik Kim
    Mi Suk Park
    Jinsil Seong
    Jeong Youp Park
    Seung Min Bang
    Si Young Song
    Jae Bock Chung
    Seung Woo Park
    Cancer Chemotherapy and Pharmacology, 2014, 73 : 191 - 198
  • [29] Epirubicin, cisplatin, and protracted venous infusion of 5-fluorouracil for advanced gastric carcinoma
    Cho, EK
    Lee, WK
    Lim, DY
    Bang, SM
    Park, DK
    Park, YH
    Kwon, OS
    Choi, DJ
    Shin, DB
    Lee, JH
    Lee, TH
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2002, 17 (03) : 348 - 352
  • [30] PHASE II STUDY OF DOCETAXEL AND 5-FLUOROURACIL (5-FU) WITH CONCURRENT RADIOTHERAPY IN PATIENTS WITH ADVANCED ESOPHAGEAL CANCER
    Hihara, J.
    Hamai, Y.
    Emi, M.
    Aoki, Y.
    Miyata, Y.
    Okada, M.
    ANNALS OF ONCOLOGY, 2010, 21 : 238 - 238
12345